Addressing MASH as a liver manifestation of the metabolic disease
Lise Lotte Gluud; Mary Rinella
MATERIALS AVAILABLE
Coming soon
13:30 - 14:00
WET
PO2-07
Publication
Fibrosis stage versus Fibrosis-4 score for predicting clinical outcomes in metabolic dysfunction-associated steatotic liver disease, and evaluation of healthcare resource utilization and associated costs
Ying Shang1; Emilie Toresson Grip1,2; Kamal Kant Mangla3; Riku Ota4; Marc Winther4; Helena Skröder1,2; Johan Vessby5; Mattias Ekstedt6; Hannes Hagström1,7